- Home
- PCRX vs THFF Comparison
PCRX vs THFF Comparison
Compare PCRX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- THFF
- Stock Information
- Founded
- PCRX 2006
- THFF 1984
- Country
- PCRX United States
- THFF United States
- Employees
- PCRX N/A
- THFF N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- THFF Major Banks
- Sector
- PCRX Health Care
- THFF Finance
- Exchange
- PCRX Nasdaq
- THFF Nasdaq
- Market Cap
- PCRX 604.7M
- THFF 599.3M
- IPO Year
- PCRX 2011
- THFF N/A
- Fundamental
- Price
- PCRX $23.33
- THFF $47.11
- Analyst Decision
- PCRX Buy
- THFF Hold
- Analyst Count
- PCRX 10
- THFF 1
- Target Price
- PCRX $27.60
- THFF $45.00
- AVG Volume (30 Days)
- PCRX 644.2K
- THFF 39.0K
- Earning Date
- PCRX 02-27-2025
- THFF 02-04-2025
- Dividend Yield
- PCRX N/A
- THFF 4.33%
- EPS Growth
- PCRX N/A
- THFF N/A
- EPS
- PCRX N/A
- THFF 3.68
- Revenue
- PCRX $694,957,000.00
- THFF $190,119,000.00
- Revenue This Year
- PCRX $4.83
- THFF N/A
- Revenue Next Year
- PCRX $2.16
- THFF $11.39
- P/E Ratio
- PCRX N/A
- THFF $12.79
- Revenue Growth
- PCRX 4.40
- THFF N/A
- 52 Week Low
- PCRX $11.16
- THFF $34.58
- 52 Week High
- PCRX $34.01
- THFF $51.87
- Technical
- Relative Strength Index (RSI)
- PCRX 72.60
- THFF 53.72
- Support Level
- PCRX $18.18
- THFF $46.45
- Resistance Level
- PCRX $22.36
- THFF $47.81
- Average True Range (ATR)
- PCRX 1.22
- THFF 1.13
- MACD
- PCRX 0.32
- THFF 0.31
- Stochastic Oscillator
- PCRX 96.63
- THFF 86.43
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.